|
 FDA approves Remicade for psoriasis treatment Sept. 27, 2006
Capitol Hill Day 2006: Record attendance, immediate results March 6, 2006
Canadian warning links hepatitis B reactivation with anti-TNF alpha drugs Feb. 2, 2006
FDA approves Remicade for psoriasis treatment Sept. 27, 2006
Leaving a legacy: A $1 million pledge from the Henschel family is a gift for the psoriasis community Sept./Oct. 2006 Psoriasis Advance
Back to school: Getting through the school year with psoriasis Sept./Oct. 2006 Psoriasis Advance
Psoriasis and the Oregon Health Plan Sept./Oct. 2006 Psoriasis Advance
The power of goals July/Aug. 2006 Psoriasis Advance
Foundation Web site garners Gold Triangle Award July/Aug. 2006 Psoriasis Advance
Capitol Hill Day 2006: The year of transformation May/June 2006 Psoriasis Advance
Winter American Academy of Dermatology: A rich exchange May/June 2006 Psoriasis Advance
Seeding new psoriasis research May/June 2006 Psoriasis Advance
Capitol Hill Day 2006: Record attendance, immediate results March 6, 2006
Research pipeline updated March/April 2006 Psoriasis Advance
Canadian warning links hepatitis B reactivation with anti-TNF alpha drugs Feb. 2, 2006
Elidel and Protopic receive black box warnings Jan. 24, 2006
FDA approves Taclonex for all plaque psoriasis treatment Jan. 11, 2006
National Psoriasis Foundation responds to USA TODAY article Jan. 5, 2006
Psoriatic arthritis basics Jan./Feb. 2006 Psoriasis Advance
Psoriasis documentary conveys message through personal experience Jan./Feb. 2006 Psoriasis Advance
2005 American College of Rheumatology highlights Jan./Feb. 2006 Psoriasis Advance
| 
